Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600115959) titled 'Clinical Observation Study on the Efficacy of Rivastigmine Hydrogen Tartrate Tablets in the Treatment of Moderate Alzheimer's Disease' on Jan. 4.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Guangdong Second Provincial General Hospital (Guangdong Provincial Emergency Hospital)
Condition:
Alzheimer's Disease
Intervention:
Observation Group (Rivastigmine Hydrogen Tartrate Tablets:NA
Control Group A (Donepezil Tablets):NA
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-05
Target Sample Size: Observation Group (Rivastigmine Hydrogen Tartrate...